Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Research Centers Select IDBS' Software to Manage Cancer Omics Data

Premium

IDBS said this week that the Segal Cancer Center at the Jewish General Hospital and the Quebec-Clinical Research Organization Consortium (Q-CROC) have selected its Translational Science Solution to mange cancer-related omics data for a personalized medicine program.

IDBS said that scientists conducting serial biopsy trials — initially with breast cancer, melanoma, and colorectal cancer patients — at these centers will use its solution to capture molecular signatures for omics data profiled from patients’ metastatic cancer tumors, which will help them choose more appropriate treatments for patients.

The software will also support a new program across Quebec that prospectively collects information on primary tumors with the aim of building a vast biobank and accompanying database that will help researchers easily identify and access patient sub-groups and will support patient stratification in drug development. Researchers will follow patients throughout their cancer trajectory including at the time of tumor relapses when the patients might participate in the Q-CROC serial biopsy trials.

Gerald Batist, director of the Segal Cancer Center and scientific director of Q-CROC, said in a statement that the centers selected IDBS platform because its data management capabilities adequately met their need for software "to capture, integrate, and analyze not only our own data" but also data from public databases and other sources.

"We anticipate it being a key tool as we join forces across the pharma industry," he added.

The financial details of the agreement were not disclosed.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.